These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28945273)

  • 61. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
    Burian B; Storka A; Marzluf BA; Yen YC; Lambers C; Robibaro B; Vonbank K; Mosgoeller W; Petkov V
    Peptides; 2010 Apr; 31(4):603-8. PubMed ID: 20026142
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).
    Huang MC; Miller AL; Wang W; Kong Y; Paul S; Goetzl EJ
    J Immunol; 2006 Jun; 176(11):6640-6. PubMed ID: 16709822
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
    Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
    Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide.
    Fabricius D; O'Dorisio MS; Blackwell S; Jahrsdörfer B
    J Immunol; 2006 Nov; 177(9):5920-7. PubMed ID: 17056516
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency.
    Langer I; Gregoire F; Nachtergael I; De Neef P; Vertongen P; Robberecht P
    Peptides; 2004 Feb; 25(2):275-8. PubMed ID: 15063009
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VPAC1 receptor binding site: contribution of photoaffinity labeling approach.
    Couvineau A; Ceraudo E; Tan YV; Laburthe M
    Neuropeptides; 2010 Apr; 44(2):127-32. PubMed ID: 20031208
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).
    Langer I; Gaspard N; Robberecht P
    Br J Pharmacol; 2006 Aug; 148(8):1051-9. PubMed ID: 16783404
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes.
    Lara-Marquez ML; O'Dorisio MS; Karacay B
    Ann N Y Acad Sci; 2000; 921():45-54. PubMed ID: 11193874
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells.
    Jimeno R; Leceta J; Martínez C; Gutiérrez-Cañas I; Carrión M; Pérez-García S; Garín M; Mellado M; Gomariz RP; Juarranz Y
    J Mol Neurosci; 2014 Nov; 54(3):512-25. PubMed ID: 24805298
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse.
    Bertolini M; Pretzlaff M; Sulk M; Bähr M; Gherardini J; Uchida Y; Reibelt M; Kinori M; Rossi A; Bíró T; Paus R
    Br J Dermatol; 2016 Sep; 175(3):531-41. PubMed ID: 27059672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.
    Erdling A; Sheykhzade M; Maddahi A; Bari F; Edvinsson L
    Neuropeptides; 2013 Apr; 47(2):85-92. PubMed ID: 23375386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway.
    Hara M; Takeba Y; Iiri T; Ohta Y; Ootaki M; Watanabe M; Watanabe D; Koizumi S; Otsubo T; Matsumoto N
    Cancer Sci; 2019 Jan; 110(1):235-244. PubMed ID: 30390393
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat.
    Chaudhary P; Baumann TK
    Brain Res Mol Brain Res; 2002 Aug; 104(2):137-42. PubMed ID: 12225867
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ca(2+)-calmodulin signalling pathway up-regulates GABA synaptic transmission through cytoskeleton-mediated mechanisms.
    Wei J; Zhang M; Zhu Y; Wang JH
    Neuroscience; 2004; 127(3):637-47. PubMed ID: 15283963
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    First NJ; Pedreira-Lopez J; San-Silvestre MRF; Parrish KM; Lu XH; Gestal MC
    Front Cell Infect Microbiol; 2023; 13():1111502. PubMed ID: 37065208
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proline residue 280 in the second extracellular loop (EC2) of the VPAC2 receptor is essential for the receptor structure.
    Vertongen P; Solano RM; Juarranz MG; Perret J; Waelbroeck M; Robberecht P
    Peptides; 2001 Sep; 22(9):1363-70. PubMed ID: 11514016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets.
    Vuckovic A; Rondelet B; Brion JP; Naeije R
    Pediatr Res; 2009 Oct; 66(4):395-9. PubMed ID: 19581838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.